Universiteit Antwerpen donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

ItemValue
Country
Facebook page UAntwerp
Websitehttps://www.uantwerp.be
Wikipedia pagehttps://en.wikipedia.org/wiki/University_of_Antwerp

Donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 6 110,000 1,832,532 -4,583 -4,583 63,258 63,258 110,000 110,000 3,095,548 3,722,168 3,722,168 4,008,801 4,008,801
Global health 6 110,000 1,832,532 -4,583 -4,583 63,258 63,258 110,000 110,000 3,095,548 3,722,168 3,722,168 4,008,801 4,008,801

Donation amounts by donor and year for donee Universiteit Antwerpen

Donor Total 2017 2016 2015
Bill and Melinda Gates Foundation (filter this donee) 10,995,192.00 4,008,801.00 3,717,585.00 3,268,806.00
Total 10,995,192.00 4,008,801.00 3,717,585.00 3,268,806.00

Full list of donations in reverse chronological order (6 donations)

DonorAmount (current USD)Amount rank (out of 6)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation4,008,801.0012017-10-30Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support phase I clinical trials with the new oral polio vaccine-2 formulation. New OPV Clinical Trials: Phase I studies. Investment start date: 11/8/2016 to end date: 7/31/2019. Grantee name: Universiteit Antwerpen; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-4,583.0062016-11-21Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support the planning of a phase I clinical trial in Belgium for the Oral Polio Vaccines being developed by a consortium of researchers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation3,722,168.0022016-11-08Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support phase I clinical trials with the new oral polio vaccine-2 formulation. New OPV Clinical Trials: Phase I studies. Investment start date: 11/8/2016 to end date: 7/31/2019. Grantee name: Universiteit Antwerpen; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation63,258.0052015-11-29Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to evaluate the infant response to pneumococcal vaccination in a Belgian cohort of infants whose mothers were previously vaccinated with tetanus, diphtheria, acellular pertussis vaccine (Tdap); Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation3,095,548.0032015-10-20Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support the implementation of phase IV clinical trials in adults to evaluate the safety and reactogenicity of monovalent type 2 and trivalent Oral Polio Vaccine for future comparisons with data on new Oral Polio Vaccines; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation110,000.0042015-06-17Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to support the planning of a phase I clinical trial in Belgium for the Oral Polio Vaccines being developed by a consortium of researchers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.